Status:
UNKNOWN
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
Lead Sponsor:
BeerYaakov Mental Health Center
Conditions:
Pathological Gambling
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Pathological gambling (PG) is characterized by a persistent pattern of continued gambling behavior despite its adverse consequences. PG is a chronic, progressive, male-dominated disorder, which has a ...
Detailed Description
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for cessation of pathological gambling Introduction: Pathological gambling (PG) is characterized by a persistent pattern of continued ...
Eligibility Criteria
Inclusion
- Pathological gambling according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
Exclusion
- History of a primary major psychiatric or cognitive disorder according to DSM IV apart from Pathological gambling.
- Current alcohol or other substance abuse or dependence.
- Alcohol or other substance abuse or dependence during the last 12 months before recruitment.
- History of or evidence of significant brain malformation or neoplasm, head injury, cerebral vascular events, neurodegenerative disorder affecting the brain or prior brain surgery.
- Significant neurological co-morbidity.
- psychiatric co-morbidity.
- psychotropic medications.
- Severe somatic co morbidity.
- Cardiac pace makers, other electronic implants, intracranial metallic particles.
- History of seizures or epileptiform activity.
- Pregnancy and lactation.
- Patients who cannot communicate reliably with the investigator or who are not likely to cope with the requirements of the experiment.
- Patients unwilling or unable to give written informed consent.
- Patients with a high risk for severe violence or suicidality as assessed during the screening interview.
- Participation in a clinical trial within the last 30 days before the beginning of this clinical trial or similar participation in another clinical trial.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01154712
Start Date
June 1 2010
End Date
June 1 2012
Last Update
July 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beer Yaakov Mental Health Center
Beer Yaakov, Hashfela, Israel, 70350